{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:07:23Z","timestamp":1793390843139,"version":"4.5.0"},"reference-count":102,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder characterized by a high incidence rate and multiple complications, posing significant threats to women\u2019s health and quality of life. The etiology of PCOS involves a complex interplay of genetic, metabolic, hormonal, immunological and environmental factors, though its precise mechanisms remain incompletely understood. This review explores the roles of oxidative stress, autophagy, ferroptosis, epigenetic modifications, post-translational modifications, chronic low-grade inflammation, and gut microbiota in the pathogenesis of PCOS. Current therapeutic strategies often combine lifestyle modifications with pharmacological interventions to address the multifaceted symptoms of PCOS. Drawing on the latest research, this review highlights advanced glycation end products (AGEs), sex hormone-binding globulin (SHBG), and microRNAs (miRNAs) as promising targets for PCOS prevention and treatment. Future research should focus on developing targeted drugs for these molecular pathways, offering new avenues for managing PCOS. This review will provide a scientific foundation for advancing PCOS treatment strategies.<\/jats:p>","DOI":"10.3389\/fendo.2025.1722649","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:41:08Z","timestamp":1769406068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome"],"prefix":"10.3389","volume":"16","author":[{"given":"Yawen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/tacg.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of pcos as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02178","article-title":"Functional genetic variation in the anti-m\u00fcllerian hormone pathway in women with polycystic ovary syndrome","volume":"104","author":"Gorsic","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02496","article-title":"Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome","volume":"104","author":"Dapas","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"Cd007506","DOI":"10.1002\/14651858.CD007506.pub4","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.7.4105","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod BioMed Online"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05951-2","article-title":"Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update","volume":"303","author":"Abraham Gnanadass","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/nu15092230","article-title":"Effect of high fat diet on disease development of polycystic ovary syndrome and lifestyle intervention strategies","volume":"15","author":"Han","year":"2023","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0088724","DOI":"10.1128\/msphere.00887-24","article-title":"Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection","volume":"10","author":"Dong","year":"2025","journal-title":"mSphere"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13854","DOI":"10.1111\/aji.13854","article-title":"Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS","volume":"91","author":"Chen","year":"2024","journal-title":"Am J Reprod Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13048-021-00867-0","article-title":"The abnormal level of HSP70 is related to Treg\/Th17 imbalance in PCOS patients","volume":"14","author":"Yang","year":"2021","journal-title":"J Ovarian Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470283","article-title":"Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome","volume":"15","author":"Deng","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104154","article-title":"Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies","volume":"82","author":"Larsson","year":"2022","journal-title":"EBioMedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2147\/nss.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","author":"Fernandez","year":"2018","journal-title":"Nat Sci Sleep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2008.12.001","article-title":"Disturbed stress responses in women with polycystic ovary syndrome","volume":"34","author":"Benson","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/humupd\/dmt015","article-title":"Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines","volume":"19","author":"Moran","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/nu14081649","article-title":"Effects of Vitamin D on fertility, pregnancy and polycystic ovary syndrome-a review","volume":"14","author":"V\u00e1rb\u00edr\u00f3","year":"2022","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)61174-1","article-title":"Oxidative stress and its implications in female infertility - a clinician\u2019s perspective","volume":"11","author":"Agarwal","year":"2005","journal-title":"Reprod BioMed Online"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.123.065827","article-title":"Polycystic ovary syndrome fuels cardiovascular inflammation and aggravates ischemic cardiac injury","volume":"148","author":"Gao","year":"2023","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00516-1","article-title":"Ketogenic diet as a possible non-pharmacological therapy in main endocrine diseases of the female reproductive system: a practical guide for nutritionists","volume":"12","author":"Camajani","year":"2023","journal-title":"Curr Obes Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4579831","article-title":"Role of oxidative stress in obese and nonobese pcos patients","volume":"2022","author":"U\u00e7kan","year":"2022","journal-title":"Int J Clin Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-022-00455-x","article-title":"Mitochondrial function and oxidative stress in white adipose tissue in a rat model of PCOS: effect of SGLT2 inhibition","volume":"13","author":"Pruett","year":"2022","journal-title":"Biol Sex Differ"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.12.049","article-title":"The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome","volume":"229","author":"Jamilian","year":"2018","journal-title":"J Affect Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2023.2238577","article-title":"The constructive and destructive impact of autophagy on both genders\u2019 reproducibility, a comprehensive review","volume":"19","author":"Samare-Najaf","year":"2023","journal-title":"Autophagy"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2021.1938914","article-title":"Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective","volume":"17","author":"Kumariya","year":"2021","journal-title":"Autophagy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00018-023-05091-1","article-title":"BOP1 contributes to the activation of autophagy in polycystic ovary syndrome via nucleolar stress response","volume":"81","author":"Ji","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/rep-10-0489","article-title":"Autophagy is a cell survival program for female germ cells in the murine ovary","volume":"141","author":"Gawriluk","year":"2011","journal-title":"Reproduction"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5880","DOI":"10.3390\/jcm13195880","article-title":"A systematic review of metabolic syndrome: key correlated pathologies and non-invasive diagnostic approaches","volume":"13","author":"Giangregorio","year":"2024","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113817","article-title":"Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated JAK-STAT3 pathway","volume":"146","author":"Zhou","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.11.021","article-title":"Leonurine restrains granulosa cell ferroptosis through SLC7A11\/GPX4 axis to promote the treatment of polycystic ovary syndrome","volume":"226","author":"Huang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/13510002.2024.2445398","article-title":"Synergistic effects of AgNPs and zileuton on PCOS via ferroptosis and inflammation mitigation","volume":"30","author":"Eltokhy","year":"2025","journal-title":"Redox Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/joe-20-0155","article-title":"Hyperandrogenism and insulin resistance modulate gravid uterine and placental ferroptosis in PCOS-like rats","volume":"246","author":"Zhang","year":"2020","journal-title":"J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoae013","article-title":"Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS","volume":"2024","author":"Li","year":"2024","journal-title":"Hum Reprod Open"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1146971","article-title":"Regulatory mechanism and research progress of ferroptosis in obstetrical and gynecological diseases","volume":"11","author":"Wang","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.21037\/atm-21-4174","article-title":"Involvement of ferroptosis in the granulosa cells proliferation of PCOS through the circRHBG\/miR-515\/SLC7A11 axis","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967151","article-title":"MiR-93-5p promotes granulosa cell apoptosis and ferroptosis by the NF-kB signaling pathway in polycystic ovary syndrome","volume":"13","author":"Tan","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1024320","article-title":"Posttranslational modifications in pathogenesis of PCOS","volume":"13","author":"Wei","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3390\/biom9120888","article-title":"Advanced glycation end products (ages) may be a striking link between modern diet and health","volume":"9","author":"Gill","year":"2019","journal-title":"Biomolecules"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/thc-218002","article-title":"DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of polycystic ovary syndrome (PCOS)","volume":"29","author":"Zhong","year":"2021","journal-title":"Technol Health Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-14-78","article-title":"CYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girls","volume":"14","author":"Stueve","year":"2014","journal-title":"BMC Pediatr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2019.86060","article-title":"Role of epigenetic modifications in the aberrant CYP19A1 gene expression in polycystic ovary syndrome","volume":"15","author":"Hosseini","year":"2019","journal-title":"Arch Med Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.mce.2015.07.002","article-title":"HDAC inhibitor prevents LPS mediated inhibition of CYP19A1 expression and 17\u03b2-estradiol production in granulosa cells","volume":"414","author":"Mehta","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13048-025-01619-0","article-title":"Correlation between the follicular fluid extracellular-vesicle-derived microRNAs and signaling disturbance in the oocytes of women with polycystic ovary syndrome","volume":"18","author":"Liao","year":"2025","journal-title":"J Ovarian Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3892\/mmr.2022.12734","article-title":"Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3\/miR\u2212223\/GLUT4 and SNHG20\/miR\u22124486\/GLUT4 signaling","volume":"26","author":"Liu","year":"2022","journal-title":"Mol Med Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802829R","article-title":"Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s43032-019-00026-3","article-title":"Pro-inflammatory markers negatively regulate IRS1 in endometrial cells and endometrium from women with obesity and PCOS","volume":"27","author":"Or\u00f3stica","year":"2020","journal-title":"Reprod Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2019.01.020","article-title":"Oxidative stress increases the 17,20-lyase-catalyzing activity of adrenal P450c17 through p38\u03b1 in the development of hyperandrogenism","volume":"484","author":"Zhu","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12958-021-00823-z","article-title":"TRIB3 regulates FSHR expression in human granulosa cells under high levels of free fatty acids","volume":"19","author":"Wang","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153958","article-title":"Dihydrotestosterone induces reactive oxygen species accumulation and mitochondrial fission leading to apoptosis of granulosa cells","volume":"509","author":"Li","year":"2024","journal-title":"Toxicology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2674%","article-title":"Strong effect of pubertal status on metabolic health in obese children: a longitudinal study","volume":"100","author":"Reinehr","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2023.05.009","article-title":"Aristolochic acid I exposure triggers ovarian dysfunction by activating NLRP3 inflammasome and affecting mitochondrial homeostasis","volume":"204","author":"Sun","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.787876","article-title":"IL-15 participates in the pathogenesis of polycystic ovary syndrome by affecting the activity of granulosa cells","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-090711-163814","article-title":"The human microbiome: our second genome","volume":"13","author":"Grice","year":"2012","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1142041","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications","volume":"13","author":"Sun","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808508","article-title":"Gut and vaginal microbiomes in pcos: implications for women\u2019s health","volume":"13","author":"Gu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01041-8","article-title":"The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice","volume":"6","author":"Yun","year":"2024","journal-title":"Nat Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135844","article-title":"Cordyceps polysaccharide improves polycystic ovary syndrome by inhibiting gut-derived LPS\/TLR4 pathway to attenuates insulin resistance","volume":"280","author":"Zhang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2024.12.003","article-title":"Early-life gut inflammation drives sex-dependent shifts in the microbiome-endocrine-brain axis","volume":"125","author":"Sullivan","year":"2025","journal-title":"Brain Behav Immun"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e0429123","DOI":"10.1128\/spectrum.04291-23","article-title":"Dysbiotic alteration in the fecal microbiota of patients with polycystic ovary syndrome","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol Spectr"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2236749","article-title":"Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism","volume":"15","author":"Hu","year":"2023","journal-title":"Gut Microbes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front Microbiol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01481-5","article-title":"Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome","volume":"44","author":"Liang","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/joe-21-0143","article-title":"AGEs-related dysfunctions in PCOS: evidence from animal and clinical research","volume":"251","author":"Tatone","year":"2021","journal-title":"J Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2019.01.005","article-title":"Implications and future perspectives of AGEs in PCOS pathophysiology","volume":"30","author":"Merhi","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160714094404","article-title":"Do advanced glycation end products (AGEs) contribute to the comorbidities of polycystic ovary syndrome (PCOS)","volume":"22","author":"Rutkowska","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-016-0205-6","article-title":"Relationship between advanced glycation end products and steroidogenesis in PCOS","volume":"14","author":"Garg","year":"2016","journal-title":"Reprod Biol Endocrinol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1177\/1535370215584937","article-title":"Advanced glycation end-products and insulin signaling in granulosa cells","volume":"241","author":"Diamanti-Kandarakis","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/nu14050966","article-title":"Impact of dietary advanced glycation end products on female reproduction: review of potential mechanistic pathways","volume":"14","author":"Mouanness","year":"2022","journal-title":"Nutrients"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1321878","article-title":"Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression","volume":"44","author":"Ishibashi","year":"2012","journal-title":"Horm Metab Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7921","article-title":"Aminoguanidine reduces diabetes-associated cardiac fibrosis","volume":"18","author":"Magdaleno","year":"2019","journal-title":"Exp Ther Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"R71","DOI":"10.1186\/ar2700","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes","volume":"11","author":"Rasheed","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e14082","DOI":"10.1111\/eci.14082","article-title":"The relationship between sex hormone-binding protein and non-alcoholic fatty liver disease using Mendelian randomisation","volume":"54","author":"Dong","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.10.003","article-title":"Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis","volume":"42","author":"Li","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2019.1587604","article-title":"AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome","volume":"39","author":"Calzada","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12902-024-01789-w","article-title":"Obesity is associated with SHBG levels rather than blood lipid profiles in PCOS patients with insulin resistance","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.12.007","article-title":"The molecular mechanism of miR-96-5p in the pathogenesis and treatment of polycystic ovary syndrome","volume":"256","author":"Liu","year":"2023","journal-title":"Transl Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.04.082","article-title":"The role of MiRNA in polycystic ovary syndrome (PCOS)","volume":"706","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1969193","article-title":"MicroRNA-21 regulate the cell apoptosis and cell proliferation of polycystic ovary syndrome (PCOS) granulosa cells through target toll like receptor TLR8","volume":"12","author":"Yu","year":"2021","journal-title":"Bioengineered"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1093\/biolre\/ioad017","article-title":"Circ_0115118 regulates endometrial functions through the miR-138-1-3p\/WDFY2 axis in patients with PCOS","volume":"108","author":"Yang","year":"2023","journal-title":"Biol Reprod"},{"key":"B93","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/genes5030684","article-title":"Micrornas related to polycystic ovary syndrome (PCOS)","volume":"5","author":"S\u00f8rensen","year":"2014","journal-title":"Genes (Basel)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-022-00876-6","article-title":"Follicular fluid-derived exosomal miR-143-3p\/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome","volume":"20","author":"Cao","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13293-024-00630-2","article-title":"MicroRNA-21 modulates brown adipose tissue adipogenesis and thermogenesis in a mouse model of polycystic ovary syndrome","volume":"15","author":"Rezq","year":"2024","journal-title":"Biol Sex Differ"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.21037\/atm-21-1288","article-title":"Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation","volume":"9","author":"Qin","year":"2021","journal-title":"Ann Transl Med"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00174","article-title":"The role of micrornas in ovarian granulosa cells in health and disease","volume":"10","author":"Tu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-018-0808-0","article-title":"Evaluation of serum mirna-24, mirna-29a and mirna-502-3p expression in PCOS subjects: correlation with biochemical parameters related to PCOS and insulin resistance","volume":"35","author":"Nanda","year":"2020","journal-title":"Indian J Clin Biochem"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2218","article-title":"Effects of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21, miRNA-27b, miRNA-103, and miRNA-155 expression","volume":"98","author":"Murri","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-024-07379-4","article-title":"miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery","volume":"309","author":"Rashid","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118174","article-title":"miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review","volume":"259","author":"Abdalla","year":"2020","journal-title":"Life Sci"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1269266","article-title":"Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS)","volume":"14","author":"Hadidi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1722649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:41:10Z","timestamp":1769406070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1722649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":102,"alternative-id":["10.3389\/fendo.2025.1722649"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1722649","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"article-number":"1722649"}}